Two-dimensional infrared spectra reveal relaxation of the nonnucleoside inhibitor TMC278 complexed with HIV-1 reverse transcriptase. 2008

Chong Fang, and Joseph D Bauman, and Kalyan Das, and Amanda Remorino, and Eddy Arnold, and Robin M Hochstrasser
Department of Chemistry, University of Pennsylvania, Philadelphia, PA 19104-6323, USA.

The two nitrile groups at the wings of the nonnucleoside HIV-1 reverse transcriptase (RT) inhibitor TMC278 are both identified in high-sensitivity 2D IR spectroscopy experiments of the HIV-1 RT/TMC278 complex. The vibrational spectra indicate that the two arms of the inhibitor sense quite different environments within the hydrophobic pocket. The vibrational relaxation of the two arms are almost equal at 3 ps from model studies. The 2D IR spectra expose a significant distribution of nitrile frequencies that diffuse at equilibrium on ultrafast time scales ranging from hundreds of femtoseconds to tens of picoseconds. The slow spectral diffusion of the cyanovinyl arm of the inhibitor is attributed to its interaction with the backbone and side chains in the hydrophobic tunnel. The results show that the inhibitor cyano modes lose memory of their structural configurations relative to the hydrophobic pocket within tens of picoseconds. The cross-peaks between the two arms of the drug are tentatively attributed to relaxation of the nitrile state with both arms excited.

UI MeSH Term Description Entries
D009570 Nitriles Organic compounds containing the -CN radical. The concept is distinguished from CYANIDES, which denotes inorganic salts of HYDROGEN CYANIDE. Nitrile
D011487 Protein Conformation The characteristic 3-dimensional shape of a protein, including the secondary, supersecondary (motifs), tertiary (domains) and quaternary structure of the peptide chain. PROTEIN STRUCTURE, QUATERNARY describes the conformation assumed by multimeric proteins (aggregates of more than one polypeptide chain). Conformation, Protein,Conformations, Protein,Protein Conformations
D011743 Pyrimidines A family of 6-membered heterocyclic compounds occurring in nature in a wide variety of forms. They include several nucleic acid constituents (CYTOSINE; THYMINE; and URACIL) and form the basic structure of the barbiturates.
D004791 Enzyme Inhibitors Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. Enzyme Inhibitor,Inhibitor, Enzyme,Inhibitors, Enzyme
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000068696 Rilpivirine A diarylpyrimidine derivative and REVERSE TRANSCRIPTASE INHIBITOR with antiviral activity against HIV-1 that is used in the treatment of HIV INFECTIONS. It is also used in combination with other ANTI-HIV AGENTS, since ANTIVIRAL DRUG RESISTANCE emerges rapidly when it is used alone. R278474,Rilpivirine HCl,Rilpivirine Hydrochloride,TMC 278,TMC-278,TMC278,278, TMC,HCl, Rilpivirine,Hydrochloride, Rilpivirine
D017550 Spectroscopy, Fourier Transform Infrared A spectroscopic technique in which a range of wavelengths is presented simultaneously with an interferometer and the spectrum is mathematically derived from the pattern thus obtained. FTIR,Fourier Transform Infrared Spectroscopy,Spectroscopy, Infrared, Fourier Transform
D054303 HIV Reverse Transcriptase A reverse transcriptase encoded by the POL GENE of HIV. It is a heterodimer of 66 kDa and 51 kDa subunits that are derived from a common precursor protein. The heterodimer also includes an RNAse H activity (RIBONUCLEASE H, HUMAN IMMUNODEFICIENCY VIRUS) that plays an essential role the viral replication process. Reverse Transcriptase, HIV,Reverse Transcriptase, Human Immunodeficiency Virus,Transcriptase, HIV Reverse
D019380 Anti-HIV Agents Agents used to treat AIDS and/or stop the spread of the HIV infection. These do not include drugs used to treat symptoms or opportunistic infections associated with AIDS. AIDS Drug,AIDS Drugs,Anti-AIDS Agents,Anti-AIDS Drug,Anti-HIV Agent,Anti-HIV Drug,Anti-AIDS Drugs,Anti-HIV Drugs,Agent, Anti-HIV,Agents, Anti-AIDS,Agents, Anti-HIV,Anti AIDS Agents,Anti AIDS Drug,Anti AIDS Drugs,Anti HIV Agent,Anti HIV Agents,Anti HIV Drug,Anti HIV Drugs,Drug, AIDS,Drug, Anti-AIDS,Drug, Anti-HIV,Drugs, AIDS,Drugs, Anti-AIDS,Drugs, Anti-HIV

Related Publications

Chong Fang, and Joseph D Bauman, and Kalyan Das, and Amanda Remorino, and Eddy Arnold, and Robin M Hochstrasser
February 2010, Antimicrobial agents and chemotherapy,
Chong Fang, and Joseph D Bauman, and Kalyan Das, and Amanda Remorino, and Eddy Arnold, and Robin M Hochstrasser
October 2004, Current HIV research,
Chong Fang, and Joseph D Bauman, and Kalyan Das, and Amanda Remorino, and Eddy Arnold, and Robin M Hochstrasser
December 1990, Science (New York, N.Y.),
Chong Fang, and Joseph D Bauman, and Kalyan Das, and Amanda Remorino, and Eddy Arnold, and Robin M Hochstrasser
August 1998, The EMBO journal,
Chong Fang, and Joseph D Bauman, and Kalyan Das, and Amanda Remorino, and Eddy Arnold, and Robin M Hochstrasser
August 2019, Antimicrobial agents and chemotherapy,
Chong Fang, and Joseph D Bauman, and Kalyan Das, and Amanda Remorino, and Eddy Arnold, and Robin M Hochstrasser
March 2008, Current HIV research,
Chong Fang, and Joseph D Bauman, and Kalyan Das, and Amanda Remorino, and Eddy Arnold, and Robin M Hochstrasser
April 2011, Antimicrobial agents and chemotherapy,
Chong Fang, and Joseph D Bauman, and Kalyan Das, and Amanda Remorino, and Eddy Arnold, and Robin M Hochstrasser
January 1996, Biochemistry,
Chong Fang, and Joseph D Bauman, and Kalyan Das, and Amanda Remorino, and Eddy Arnold, and Robin M Hochstrasser
November 2009, Journal of acquired immune deficiency syndromes (1999),
Chong Fang, and Joseph D Bauman, and Kalyan Das, and Amanda Remorino, and Eddy Arnold, and Robin M Hochstrasser
June 1997, Biochemistry,
Copied contents to your clipboard!